BioNTech Looks To AI Partnership To Accelerate Drug Discovery

Cancer And Infectious Disease Pipeline Could Benefit

The German biotech has developed its COVID-19 vaccine in record-breaking time, but artificial intelligence could help accelerate drug discovery over the longer term.

Mainz, Rheinland-Pfalz, Germany-9. September 2020 Biontech building in Mainz with the sun shining and waving flags
BioNTech wants to speed up the drug discovery process with AI partners InstaDeep

While BioNTech has the historic task of bringing its COVID-19 vaccine to patients around the world, it is still looking to speed up

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from AI

More from Digital Technologies